3UJ-30738-59675
3 vaccinations
13 coded responses
32 check-ins
13 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 021 / MA
- Registered
- 2021-06-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-21
Registered in v-safe
-
2021-06-21
Dose 1 — Pfizer-BioNTech
-
2021-06-21
Survey response — day 0, dose 1MedDRA: Eye pruritus — Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness, NauseaFree text: Itchy eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-22
Survey response — days 1–6 daily, dose 1MedDRA: Vision blurred — Feeling: Good · Site: Pain · HeadacheFree text: Blurry visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-23
Survey response — days 1–6 daily, dose 1MedDRA: Vision blurred — Feeling: Good · HeadacheFree text: Blurry visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-24
- 2021-06-25
- 2021-06-26
- 2021-06-27
- 2021-06-28
- 2021-07-12
-
2021-07-13
Dose 2 — Pfizer-BioNTech
- 2021-07-13
-
2021-07-14
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: SweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-15
Survey response — days 1–6 daily, dose 2MedDRA: Brain fog — Feeling: Good · Site: Pain, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Brain fogMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, DiarrheaAdult check-in
- 2021-07-17
- 2021-07-18
- 2021-07-19
- 2021-07-20
- 2021-07-27
-
2021-08-03
Survey response — day 21, dose 2MedDRA: Autoimmune disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Autoimmune symptomsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-12
Survey response — day 28, dose 2MedDRA: Immune system disorder, Malignant mast cell neoplasm — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Yes, but probably not related to the shot. Mast cell and immunological symptoms.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-17
Survey response — day 35, dose 2MedDRA: Autoimmune disorder, Brain fog, Endocrine disorder, Lethargy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Increase in brain fog, lethargy, and autoimmune/endocrine things. Probably not vaccine related.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-26
Survey response — day 42, dose 2MedDRA: Autoimmune disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Autoimmune (still trying to figure out which)MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-12
-
2022-02-06
Dose 3 — Pfizer-BioNTech
-
2022-02-06
Survey response — day 0, dose 3MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, NauseaFree text: Lightheadedness/dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-02-07
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness, Dyspnoea, Hyperhidrosis, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Shortness of breath, congestion, runny nose, lightheadedness, sweatsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-08
Survey response — days 1–6 daily, dose 3MedDRA: Cough, Hyperhidrosis — Feeling: Good · Site: Pain · Fatigue or tiredness, Diarrhea, Abdominal painFree text: Cough, sweatsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Survey response — days 1–6 daily, dose 3MedDRA: Abdominal distension, Cough, Hyperhidrosis, Lymphadenopathy — Feeling: Fair · Chills, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sweats, cough, swollen lymph nodes, bloatingMedDRA releases: 2024-11 · check-in free text available
-
2022-02-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Itching · Headache, Fatigue or tirednessAdult check-in
-
2022-02-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Itching · Fatigue or tirednessAdult check-in
- 2022-02-12
- 2022-02-13
- 2022-03-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-21 | Pfizer-BioNTech | No |
| 2 | 2021-07-13 | Pfizer-BioNTech | No |
| 3 | 2022-02-06 | Pfizer-BioNTech | No |
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): Itchy eyes
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Blurry vision
Systemic reaction (other): Blurry vision
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Sweats
Systemic reaction (other): Brain fog
Release 9 — day 21, dose 2
Symptoms: Autoimmune symptoms
Release 9 — day 28, dose 2
Symptoms: Yes, but probably not related to the shot. Mast cell and immunological symptoms.
Release 9 — day 35, dose 2
Symptoms: Increase in brain fog, lethargy, and autoimmune/endocrine things. Probably not vaccine related.
Release 9 — day 42, dose 2
Symptoms: Autoimmune (still trying to figure out which)
Release 11 — day 0, dose 3
Systemic reaction (other): Lightheadedness/dizziness
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Shortness of breath, congestion, runny nose, lightheadedness, sweats
Systemic reaction (other): Cough, sweats
Systemic reaction (other): Sweats, cough, swollen lymph nodes, bloating
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Autoimmune disorder | ✓ | · | ✓ |
| SD | Brain fog | ✓ | · | ✓ |
| SD | Endocrine disorder | ✓ | · | ✓ |
| SD | Immune system disorder | ✓ | · | ✓ |
| SD | Lethargy | ✓ | · | ✓ |
| SD | Malignant mast cell neoplasm | ✓ | · | ✓ |
| SRO | Abdominal distension | · | · | ✓ |
| SRO | Brain fog | ✓ | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Eye pruritus | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release